Warfarin-related recurrent knee haemarthrosis treated with arterial embolisation and intra-articular injection of tranexamic acid

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Kunugiza, Yasuo ^a   Nakamura, Yoshiharu ^a   Mikami, Koji ^a   Suzuki, Shozo ^a  

^a Suita Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID; WARFARIN; ANTICOAGULANT AGENT; ANTIFIBRINOLYTIC AGENT;

ADULT; ANGIOGRAPHY; AORTA VALVE REGURGITATION; AORTIC VALVE REPAIR; ARTICLE; ARTIFICIAL EMBOLISM; CASE REPORT; EMBOLISM; FEMALE; FOLLOW UP; HEMARTHROSIS; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; JOINT ASPIRATION; KNEE DISEASE; KNEE HEMARTHROSIS; KNEE PAIN; LABORATORY TEST; LEUKOCYTE COUNT; MECHANICAL HEART VALVE; MIDDLE AGED; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; NEUTROPHILIA; OUTCOME ASSESSMENT; PACEMAKER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHEUMATIC FEVER; SWELLING; ARTIFICIAL EMBOLIZATION; CHEMICALLY INDUCED; COMPLICATION; INTRAARTICULAR DRUG ADMINISTRATION; KNEE; MAGNETIC RESONANCE ANGIOGRAPHY; PATHOLOGY; RECURRENT DISEASE; TREATMENT OUTCOME;

ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; EMBOLIZATION, THERAPEUTIC; FEMALE; HEMARTHROSIS; HUMANS; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; RECURRENCE; TRANEXAMIC ACID; TREATMENT OUTCOME; WARFARIN;

EID: 84939635270     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2015-210203     Document Type: Article

References (18)

1. Rodriguez-Merchan EC. Cartilage damage in the haemophilic joints: pathophysiology, diagnosis and management. Blood Coagul Fibrinolysis 2012;23:179-83.
2. Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl 1987;137:22-5.
3. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:160S-98S.
4. Conway EM, Bauer KA, Barzegar S, et al. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest 1987;80:1535-44.
5. Jerkeman A, Astermark J, Hedner U, et al. Correlation between different intensities of anti-vitamin K treatment and coagulation parameters. Thromb Res 2000;98:467-71.
6. Schulman S, Schoenberg J, Divakara Menon S, et al. Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion. Throbosis Res 2013;131:300-3.
7. Baber U, van der Zee S, Fuster V. Anticoagulation for mechanical heart valves in patients with and without atrial fibrillation. Curr Cardiol Rep 2010;12:133-9.
8. Navgren M, Forsblad J, Wieloch M. Bleeding complications related to warfarin treatment: a descriptive register study from the anticoagulation clinic at Helsingborg Hospital. J Thromb Thrombolysis 2014;38:98-104.
9. Forsyth AL, Zourikian N, Valentino LA, et al. The effect of cooling on coagulation and haemostasis: should "Ice" be part of treatment of acute haemarthrosis in haemophilia? Haemophilia 2012;18:843-50.
10. Son KM, Kim JK, Seo YI, et al. A case of bilateral hemarthrosis due to pseudoaneurysms in a patient on anticoagulation therapy. J Clin Rheumatol 2013;19:206-8.
11. Tan YK, Lai HK, Chong YY. Use of radiosynovectomy in recurrent warfarin-related haemarthrosis in degenerative arthritis. Singapore Med J 2011;52:e184-6.
12. Iwai T, Tsuji S, Tomita T, et al. Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop 2013;37:441-5.
13. Mutsuzaki H, Ikeda K. Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J Orthop Surg Res 2012;7:32.
14. Gillette BP, DeSimone LJ, Trousdale RT, et al. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res 2013;471:150-4.
15. Carter G, Goss A, Lloyd J, et al. Tranexamic acid mouthwash versus autologous fibrin glue in patients taking warfarin undergoing dental extractions: a randomized prospective clinical study. J Oral Maxillofac Surg 2003;61:1432-5.
16. Aoki M, Okawa Y, Goto Y, et al. Local administration of tranexamic acid in off-pump coronary artery bypass. Asian Cardiovasc Thorac Ann 2012;20:658-62.
17. Andersson L, Nilsoon IM, Colleen S, et al. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA. Ann N Y Acad Sci 1968;146:642-58.
18. Incampo F, Carrieri C, Galasso R, et al. Effect of warfarin treatment on thrombin activatable fibrinolysis inhibitor (TAFI) activation and TAFI-mediated inhibition of fibrinolysis. J Thromb Haemost 2013;11:315-24.